The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib

Ruxolitinib is increasingly being utilized for the treatment of myelofibrosis and polycythemia vera, but the potential for hepatic toxicity is poorly understood. We performed a retrospective review of hepatic damage occurring in patients with myeloproliferative neoplasms receiving ruxolitinib. Relev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Douglas, Putra, Juan, Vogel, Alexander, Winters, Adam, Hoffman, Ronald, Schiano, Thomas D., Fiel, Maria Isabel, Mascarenhas, John O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339753/
https://www.ncbi.nlm.nih.gov/pubmed/30723558
http://dx.doi.org/10.1155/2019/3294046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339753/
https://www.ncbi.nlm.nih.gov/pubmed/30723558
http://dx.doi.org/10.1155/2019/3294046

Ejemplares similares